FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/09/2024
Back to search
Official data from USPTO
STIPE THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
STIPE THERAPEUTICS
ST13
US500000079363664Class
1, 5, 42
Filing
79363664
Registration
7341867
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
11/09/2024
Trademark type
Word
Nice classes
1, 5, 42
Filing date
06/29/2022
Registration date
04/02/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/02/2024
Last transaction
04/02/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
66
Owner location
DK
Examiner
BIBB, SCOTT
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
S. A. (pessoa física)
Representatives
Shoko Naruo Thompson Coburn LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science; chemicals for use in manufacture of peptidessmall moleculesa wide variety of goods; biological preparations for use in industry and science; biological preparations for use in manufacture; chemicals and chemical preparations for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in the pharmaceutical industryactive chemical ingredients for use in the manufacture of pharmaceuticals for treating cancertumorigenesisautoimmune disordersother inflammatory diseases; chemicals and chemical preparations for use in biotechnological manufacturing processes; chemical and chemical preparations for use in biotechnological product development; chemicals and chemical preparations for use in the biotechnological industry; reagents for scientific purposes; reagents for medical research; enzymes for scientific purposes; enzymes for use in the manufacture of pharmaceuticals; biological preparations other than for medical use; proteins for use in industry and science; proteins for use in manufacture; peptides for use in industry and science; peptides for use in manufacture of pharmaceuticals
Class 5
Pharmaceutical preparations for the prevention of cancertumorigenesisautoimmune disordersother inflammatory diseasesmedical preparations for the treatment of cancertumorigenesisautoimmune disordersother inflammatory diseasesveterinary pharmaceutical preparations for the treatment of cancertumorigenesisautoimmune disordersother inflammatory diseases; medical preparationsadjuvants used in vaccines; sanitary preparations for medical purposes; dietetic food and preparations adapted for medical or veterinary usefood for babies; dietary supplements for human beings and animals; material for stopping teethdental wax; disinfectants; preparations for destroying vermin; fungicidesherbicides; pharmaceuticals for the treatment of cancer and autoimmune disorders; drug delivery agents in the form of intravenous administration fluids that facilitate the delivery of pharmaceutical preparations; synthetic proteins and peptides for pharmaceutical and medical purposesfor the treatment of cancertumorigenesisautoimmune disordersother inflammatory diseases; regulatory proteins and peptides for pharmaceutical and medical useprotein arrays for treating cancertumorigenesisautoimmune disordersother inflammatory diseases
Class 42
Design and development of computer hardware and software; clinical research in the field of cancertumorigenesisautoimmune disordersother inflammatory diseases; medical and scientific researchconducting clinical trials for others; drug discovery services; development of pharmaceutical preparations and medicines; research relating to medicines; medical and pharmacological research services; medical laboratories; scientific and technological servicesresearch and design in the field of medical technology; product design and development of medical apparatus; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information relating to medical and veterinary research and development
Publications
History of USPTO decisions and trademark events.
32 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/18/2024
FIMP
FINAL DISPOSITION PROCESSED
10/18/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/03/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/02/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
04/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/16/2024
PUBO
PUBLISHED FOR OPPOSITION
01/16/2024
GPNX
NOTIFICATION PROCESSED BY IB
01/13/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/27/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/27/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/16/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/16/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/16/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/13/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/13/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/13/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/13/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/13/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/13/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/06/2023
RFNT
REFUSAL PROCESSED BY IB
06/26/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/07/2023
RFRR
REFUSAL PROCESSED BY MPU
06/07/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/18/2023
CNRT
NON-FINAL ACTION WRITTEN
04/17/2023
DOCK
ASSIGNED TO EXAMINER
04/13/2023
MAFR
APPLICATION FILING RECEIPT MAILED
03/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/25/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/24/2023
Continuous trademark protection
Get notified about every new filing that threatens STIPE THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.